Annual Operating Expenses
$407.94 M
+$145.90 M+55.68%
December 31, 2024
Summary
- As of March 10, 2025, KNSA annual total operating expenses is $407.94 million, with the most recent change of +$145.90 million (+55.68%) on December 31, 2024.
- During the last 3 years, KNSA annual operating expenses has risen by +$221.87 million (+119.23%).
- KNSA annual operating expenses is now at all-time high.
Performance
KNSA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$204.06 M
+$131.60 M+181.63%
December 31, 2024
Summary
- As of March 10, 2025, KNSA quarterly total operating expenses is $204.06 million, with the most recent change of +$131.60 million (+181.63%) on December 31, 2024.
- Over the past year, KNSA quarterly operating expenses has stayed the same.
- KNSA quarterly operating expenses is now at all-time high.
Performance
KNSA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
KNSA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +55.7% | 0.0% |
| 3 y3 years | +119.2% | +300.1% |
| 5 y5 years | +140.0% | +526.3% |
KNSA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +119.2% | at high | +442.1% |
| 5 y | 5-year | at high | +159.2% | at high | +594.4% |
| alltime | all time | at high | +1599.6% | at high | +3942.4% |
Kiniksa Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $407.94 M(+55.7%) | $204.06 M(+181.6%) |
| Sep 2024 | - | $72.46 M(+9.1%) |
| Jun 2024 | - | $66.41 M(+2.1%) |
| Mar 2024 | - | $65.02 M(-42.6%) |
| Dec 2023 | $262.05 M(+39.7%) | $113.31 M(+119.7%) |
| Sep 2023 | - | $51.57 M(-2.6%) |
| Jun 2023 | - | $52.94 M(+19.7%) |
| Mar 2023 | - | $44.22 M(-32.7%) |
| Dec 2022 | $187.51 M(+0.8%) | $65.68 M(+59.6%) |
| Sep 2022 | - | $41.16 M(+9.4%) |
| Jun 2022 | - | $37.64 M(-12.5%) |
| Mar 2022 | - | $43.03 M(-15.6%) |
| Dec 2021 | $186.08 M(+18.2%) | $51.01 M(+27.5%) |
| Sep 2021 | - | $39.99 M(-12.7%) |
| Jun 2021 | - | $45.79 M(-7.1%) |
| Mar 2021 | - | $49.28 M(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $157.36 M(-7.4%) | $52.90 M(+22.4%) |
| Sep 2020 | - | $43.22 M(+35.6%) |
| Jun 2020 | - | $31.86 M(+8.4%) |
| Mar 2020 | - | $29.39 M(-9.8%) |
| Dec 2019 | $169.96 M(+57.1%) | $32.58 M(+7.0%) |
| Sep 2019 | - | $30.45 M(-22.5%) |
| Jun 2019 | - | $39.29 M(-41.9%) |
| Mar 2019 | - | $67.65 M(+53.3%) |
| Dec 2018 | $108.16 M(+65.4%) | $44.13 M(+68.7%) |
| Sep 2018 | - | $26.16 M(+21.5%) |
| Jun 2018 | - | $21.53 M(+31.7%) |
| Mar 2018 | - | $16.34 M(-50.0%) |
| Dec 2017 | $65.40 M(+172.5%) | $32.71 M(+101.3%) |
| Sep 2017 | - | $16.25 M(+42.6%) |
| Jun 2017 | - | $11.39 M(+125.7%) |
| Mar 2017 | - | $5.05 M |
| Dec 2016 | $24.00 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual operating expenses year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly operating expenses year-on-year change?
What is Kiniksa Pharmaceuticals annual total operating expenses?
The current annual operating expenses of KNSA is $407.94 M
What is the all time high annual operating expenses for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual total operating expenses is $407.94 M
What is Kiniksa Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, KNSA annual total operating expenses has changed by +$145.90 M (+55.68%)
What is Kiniksa Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of KNSA is $204.06 M
What is the all time high quarterly operating expenses for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly total operating expenses is $204.06 M
What is Kiniksa Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, KNSA quarterly total operating expenses has changed by $0.00 (0.00%)